These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 9042164)

  • 1. Role of gemistocytes in astrocytoma progression.
    Watanabe K; Tachibana O; Yonekawa Y; Kleihues P; Ohgaki H
    Lab Invest; 1997 Feb; 76(2):277-84. PubMed ID: 9042164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The significance of gemistocytes in astrocytoma.
    Yang HJ; Kim JE; Paek SH; Chi JG; Jung HW; Kim DG
    Acta Neurochir (Wien); 2003 Dec; 145(12):1097-103; discussion 1103. PubMed ID: 14663567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas.
    Lang FF; Miller DC; Pisharody S; Koslow M; Newcomb EW
    Oncogene; 1994 Mar; 9(3):949-54. PubMed ID: 8108140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies.
    Watanabe K; Sato K; Biernat W; Tachibana O; von Ammon K; Ogata N; Yonekawa Y; Kleihues P; Ohgaki H
    Clin Cancer Res; 1997 Apr; 3(4):523-30. PubMed ID: 9815715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. J1-31 protein expression in astrocytes and astrocytomas.
    Shuangshoti S; Thorner PS; Ruangvejvorachai P; Saha B; Groshen S; Taylor CR; Malhotra S; Imam SA
    Neuropathology; 2009 Oct; 29(5):521-7. PubMed ID: 19019178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
    Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
    Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
    Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
    Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction.
    Ishida H; Irie K; Itoh T; Furukawa T; Tokunaga O
    Cancer; 1997 Sep; 80(6):1034-45. PubMed ID: 9305703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of TP53 mutations and P53 protein overexpression in supratentorial WHO grade II astrocytomas and oligoastrocytomas.
    Peraud A; Kreth FW; Wiestler OD; Kleihues P; Reulen HJ
    Clin Cancer Res; 2002 May; 8(5):1117-24. PubMed ID: 12006527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.
    Fults D; Brockmeyer D; Tullous MW; Pedone CA; Cawthon RM
    Cancer Res; 1992 Feb; 52(3):674-9. PubMed ID: 1346255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic evidence of the neoplastic nature of gemistocytes in astrocytomas.
    Reis RM; Hara A; Kleihues P; Ohgaki H
    Acta Neuropathol; 2001 Nov; 102(5):422-5. PubMed ID: 11699553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of a novel point mutation in the p53 gene in grade II astrocytomas by PCR-SSCP analysis with additional Klenow treatment.
    Chawengchao B; Petmitr S; Ponglikitmongkol M; Chanyavanich V; Sangruji T; Theerapuncharoen V; Hayashi K; Thangnipon W
    Anticancer Res; 2001; 21(4A):2739-43. PubMed ID: 11724349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral granular cell astrocytomas: a Mib-1, bcl-2, and telomerase study.
    Chorny JA; Evans LC; Kleinschmidt-DeMasters BK
    Clin Neuropathol; 2000; 19(4):170-9. PubMed ID: 10919348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices.
    Ono Y; Tamiya T; Ichikawa T; Kunishio K; Matsumoto K; Furuta T; Ohmoto T; Ueki K; Louis DN
    J Neuropathol Exp Neurol; 1996 Oct; 55(10):1026-31. PubMed ID: 8857999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype.
    Rushing EJ; Brown DF; Hladik CL; Risser RC; Mickey BE; White CL
    Mod Pathol; 1998 May; 11(5):464-70. PubMed ID: 9619600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microglia in gemistocytic astrocytomas.
    Geranmayeh F; Scheithauer BW; Spitzer C; Meyer FB; Svensson-Engwall AC; Graeber MB
    Neurosurgery; 2007 Jan; 60(1):159-66; discussion 166. PubMed ID: 17228265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects.
    Reilly KM; Loisel DA; Bronson RT; McLaughlin ME; Jacks T
    Nat Genet; 2000 Sep; 26(1):109-13. PubMed ID: 10973261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of TP53 mutation status for adult patients with supratentorial World Health Organization Grade II astrocytoma or oligoastrocytoma: a long-term analysis.
    Ständer M; Peraud A; Leroch B; Kreth FW
    Cancer; 2004 Sep; 101(5):1028-35. PubMed ID: 15329912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis.
    Kajiwara Y; Yamasaki F; Hama S; Yahara K; Yoshioka H; Sugiyama K; Arita K; Kurisu K
    Cancer; 2003 Feb; 97(4):1077-83. PubMed ID: 12569609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human gliomas with wild-type p53 express bcl-2.
    Alderson LM; Castleberg RL; Harsh GR; Louis DN; Henson JW
    Cancer Res; 1995 Mar; 55(5):999-1001. PubMed ID: 7867012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.